ITI Pharma and Healthcare Fund
- NAV
- ₹19.46
- —30 Oct 2026
- AUM (₹ Cr)
- 266
- Average, July - September 2026
- Expense ratio
- 0.89%
- Regular 2.59%
- Risk
- Very High
- SEBI riskometer
- 1Y return
- 9.4%+0.4%
- Benchmark 9.0%
- 3Y CAGR
- 20.3%-0.8%
- Benchmark 21.1%
- 5Y CAGR
- —
- Category 16.1%
Rank in category
Too young for a combined rank, which needs five years. On its 1-year return it is #14 of 17.
Ranked on 1Y, 3Y and 5Y together. 8 of 19 funds have a rank here; it needs a 5-year record. Direct plan, growth option. Click a column to rank by it.
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily NAVs. Risk-free rate 6.5% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| Fund | 0.0% | -1.3% | +11.7% | +14.1% | +9.4% | +20.3% | — | — | +14.3% |
| NIFTY Healthcare TRI | — | — | — | — | 9.0% | 21.1% | — | — | 14.2% |
| Healthcare average | -0.3% | -0.9% | 13.5% | 16.7% | 14.5% | 22.4% | 16.1% | 14.7% | 16.3% |
| Difference | — | — | — | — | +0.4% | -0.8% | — | — | +0.1% |
Portfolio
Valuation
- P/E
- 49.4
- In line with its category
- Category median
- 48.4
- 19 Healthcare funds
- Benchmark P/E
- 43.6
- Nifty Healthcare
P/E is the value of the shares the fund holds, at the close of 30 Oct 2026, over their profit in the last four reported quarters (the owners' share from continuing operations, consolidated where filed, losses included), weighted by the fund's portfolio disclosed 24 Oct 2026. The category median is worked out the same way; the benchmark's is the index provider's own figure on the same basis.
Fund details
- Fund house
- ITI Mutual Fund
- Category
- Equity · Healthcare
- SEBI classification
- Equity / Sectoral / Thematic
- Benchmark
- NIFTY Healthcare TRI
- Launch date
- 11 Nov 2021 (5.0 years)
- Structure
- Open Ended
- Plans and options
- Direct Growth, Regular Growth
- Fund manager
- Animesh Singh
- Minimum SIP
- ₹500
- Minimum lumpsum
- ₹5,000 (then ₹1,000)
- Exit load
- 0.50%
- Lock-in
- None
- Riskometer
- Very High (benchmark Very High)
- Expense ratio as of
- 29 Oct 2026
- AUM period
- July - September 2026
- ISIN, Direct Growth
- INF00XX01BO9
- ISIN, Regular Growth
- INF00XX01BL5
- Scheme code
- 149268, 149270
NAV and returns as of 30 Oct 2026; returns are for the direct plan, growth option, before entry or exit costs. Not investment advice.
Other healthcare funds
Other funds in the Healthcare category.
- PGIM India Healthcare FundPGIM India Mutual Fund · ₹118 Cr · ER 0.98%
- Invesco India Pharma and Healthcare FundInvesco Mutual Fund · ₹111 Cr · ER 3.30%
- LIC MF Healthcare FundLIC Mutual Fund · ₹99 Cr · ER 1.38%
- Nippon India Pharma FundNippon India Mutual Fund · ₹9,272 Cr · ER 0.99%5Y 14.2%
- ICICI Prudential Healthcare FundICICI Prudential Mutual Fund · ₹6,830 Cr · ER 1.30%5Y 16.7%
- SBI Healthcare Opportunities FundSBI Mutual Fund · ₹5,565 Cr · ER 1.00%5Y 19.2%